102 related articles for article (PubMed ID: 22897843)
1. Genomic analysis drives tailored therapy in poor risk childhood leukemia.
Harrison CJ
Cancer Cell; 2012 Aug; 22(2):139-40. PubMed ID: 22897843
[TBL] [Abstract][Full Text] [Related]
2. Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia.
Roberts KG; Morin RD; Zhang J; Hirst M; Zhao Y; Su X; Chen SC; Payne-Turner D; Churchman ML; Harvey RC; Chen X; Kasap C; Yan C; Becksfort J; Finney RP; Teachey DT; Maude SL; Tse K; Moore R; Jones S; Mungall K; Birol I; Edmonson MN; Hu Y; Buetow KE; Chen IM; Carroll WL; Wei L; Ma J; Kleppe M; Levine RL; Garcia-Manero G; Larsen E; Shah NP; Devidas M; Reaman G; Smith M; Paugh SW; Evans WE; Grupp SA; Jeha S; Pui CH; Gerhard DS; Downing JR; Willman CL; Loh M; Hunger SP; Marra MA; Mullighan CG
Cancer Cell; 2012 Aug; 22(2):153-66. PubMed ID: 22897847
[TBL] [Abstract][Full Text] [Related]
3. Tyrosine kinome sequencing of pediatric acute lymphoblastic leukemia: a report from the Children's Oncology Group TARGET Project.
Loh ML; Zhang J; Harvey RC; Roberts K; Payne-Turner D; Kang H; Wu G; Chen X; Becksfort J; Edmonson M; Buetow KH; Carroll WL; Chen IM; Wood B; Borowitz MJ; Devidas M; Gerhard DS; Bowman P; Larsen E; Winick N; Raetz E; Smith M; Downing JR; Willman CL; Mullighan CG; Hunger SP
Blood; 2013 Jan; 121(3):485-8. PubMed ID: 23212523
[TBL] [Abstract][Full Text] [Related]
4. Towards precision medicine in childhood leukemia--insights from mutationally activated cytokine receptor pathways in acute lymphoblastic leukemia.
Izraeli S; Shochat C; Tal N; Geron I
Cancer Lett; 2014 Sep; 352(1):15-20. PubMed ID: 24569093
[TBL] [Abstract][Full Text] [Related]
5. The biology of Philadelphia chromosome-like ALL.
Roberts KG
Best Pract Res Clin Haematol; 2017 Sep; 30(3):212-221. PubMed ID: 29050694
[TBL] [Abstract][Full Text] [Related]
6. The molecular genetic makeup of acute lymphoblastic leukemia.
Mullighan CG
Hematology Am Soc Hematol Educ Program; 2012; 2012():389-96. PubMed ID: 23233609
[TBL] [Abstract][Full Text] [Related]
7. Gene variants offer clues to high-risk childhood ALL.
Jenks S
J Natl Cancer Inst; 2010 Dec; 102(23):1752-5. PubMed ID: 21088278
[No Abstract] [Full Text] [Related]
8. IL-7 and TSLP receptors: twisted sisters.
Durum SK
Blood; 2014 Jul; 124(1):4-5. PubMed ID: 24993875
[TBL] [Abstract][Full Text] [Related]
9. How new advances in genetic analysis are influencing the understanding and treatment of childhood acute leukemia.
Roberts KG; Mullighan CG
Curr Opin Pediatr; 2011 Feb; 23(1):34-40. PubMed ID: 21169835
[TBL] [Abstract][Full Text] [Related]
10. Understanding the biology of CRLF2-overexpressing acute lymphoblastic leukemia.
Tasian SK; Loh ML
Crit Rev Oncog; 2011; 16(1-2):13-24. PubMed ID: 22150304
[TBL] [Abstract][Full Text] [Related]
11. Beyond Philadelphia: 'Ph-like' B cell precursor acute lymphoblastic leukemias - diagnostic challenges and therapeutic promises.
Izraeli S
Curr Opin Hematol; 2014 Jul; 21(4):289-96. PubMed ID: 24848770
[TBL] [Abstract][Full Text] [Related]
12. Novel activating mutations lacking cysteine in type I cytokine receptors in acute lymphoblastic leukemia.
Shochat C; Tal N; Gryshkova V; Birger Y; Bandapalli OR; Cazzaniga G; Gershman N; Kulozik AE; Biondi A; Mansour MR; Twizere JC; Muckenthaler MU; Ben-Tal N; Constantinescu SN; Bercovich D; Izraeli S
Blood; 2014 Jul; 124(1):106-10. PubMed ID: 24787007
[TBL] [Abstract][Full Text] [Related]
13. [Characteristics and Clinical Significance of CRLF2 Mutations in Adult Acute Lymphoblastic Leukemia].
Gu Y; Wu YJ; Han Q; Zhou XL; Qiao C; Li JY; Ge Z
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):328-333. PubMed ID: 28446270
[TBL] [Abstract][Full Text] [Related]
14. The V617F mutation in Jak2 is not found in childhood acute lymphoblastic leukaemia.
Sulong S; Case M; Minto L; Wilkins B; Hall A; Irving J
Br J Haematol; 2005 Sep; 130(6):964-5. PubMed ID: 16156866
[No Abstract] [Full Text] [Related]
15. New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia.
Hales EC; Taub JW; Matherly LH
Cell Signal; 2014 Jan; 26(1):149-61. PubMed ID: 24140475
[TBL] [Abstract][Full Text] [Related]
16. High incidence of Philadelphia chromosome-like acute lymphoblastic leukemia in older adults with B-ALL.
Tasian SK; Hurtz C; Wertheim GB; Bailey NG; Lim MS; Harvey RC; Chen IM; Willman CL; Astles R; Zebrowski A; Reshmi SC; Li MM; Frey NV; Luger SM; Carroll M; Perl AE
Leukemia; 2017 Apr; 31(4):981-984. PubMed ID: 27932787
[No Abstract] [Full Text] [Related]
17. Lymphoid malignancies: Another face to the Janus kinases.
Scott LM
Blood Rev; 2013 Mar; 27(2):63-70. PubMed ID: 23340138
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of cytokine receptor-like factor 2 alterations in acute lymphoblastic leukemia: a meta-analysis.
Jia M; Wang ZJ; Zhao HZ; Shen HP; Cheng YP; Luo ZB; Tang YM
World J Pediatr; 2015 May; 11(2):126-33. PubMed ID: 25920591
[TBL] [Abstract][Full Text] [Related]
19. Mutational screen reveals a novel JAK2 mutation, L611S, in a child with acute lymphoblastic leukemia.
Kratz CP; Böll S; Kontny U; Schrappe M; Niemeyer CM; Stanulla M
Leukemia; 2006 Feb; 20(2):381-3. PubMed ID: 16341038
[No Abstract] [Full Text] [Related]
20. Genomic profiling of high-risk acute lymphoblastic leukemia.
Collins-Underwood JR; Mullighan CG
Leukemia; 2010 Oct; 24(10):1676-85. PubMed ID: 20739952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]